15 min, resuspended in ice-cold PBS or Dulbecco's modified Eagle's medium (GIBCO) and counted in a hemocytometer with a 40 x objective. The cultures of Y strain contained 85% epimastigotes and 15% trypomastigotes. The Tulahudn strain contained 95% epimastigotes. Purified trypomastigotes were obtained as previously described (8) .
Cell Culture NORMAL MACROPHAGES. Mouse peritoneal macrophages were obtained from Swiss mice maintained at The Rockefeller University, and C57BL/6J, A/J, and C3H/HeJ mice obtained from The Jackson Laboratory, Bar Harbor, Maine. Cells were harvested according to the methods of Cohn and Benson (11) and plated either on 13-mm round cover slips in Dulbecco's plus 10% heatinactivated fetal bovine serum (FBS), 100 U/ml penicillin and 100/~g/ml streptomycin (D10), or in ~s~I-fibrin-coated 16-ram Linbro plates (Linbro Chemical Co., New Haven, Conn.) in Dulbecco's plus 20% heat-inactivated FBS, 60 /~g/ml soybean trypsin inhibitor (STI, fraction VI; Miles Laboratories, Inc., Miles Research Div., Kankakee, Ill.), to suppress fibrinolysis, and antibiotics, as above (D20STI). The average yield of cells obtained from normal mice was 5 × 10 e, of which 45-50% were macrophages. Serial dilutions of cells were plated for most experiments, ranging from 1 x 105 to 108 cells per well.
IMMUNE MACROPHAGES. Immune macrophages were obtained from animals previously in- Cells were cultivated as described above for normal macrophages for 24 h before assays were started. Serial dilutions of cells were plated for most experiments, ranging from 105 to 106 cells per well. Average yields were: 10 x 106 cells per mouse for control challenged animals and 15-20 x 105 for immune, boosted animals from which 70-75% were macrophages and 20-25% polymorphonuclear leukocytes (PMNs) at day 2. Immune resident cells were 10 x 106 per mouse, from which 45-50% were macrophages, 45-50% lymphocytes, and about 5% PMNs.
Assays
FIBRINOLYSIS ASSAY. Fibrinolysis was assayed on ~25I-fibrin-coated 16-mm Linbro plates as described elsewhere (12) . The plates contained 10/~g fibrinogen/cm 2 and 5 x 105 trypsin-releasable cpm. Peritoneal cells were plated on 125I-fibrin-coated plates in D20STI. 2 h later nonadherent cells were removed by washing the plates three times with Hanks' balanced salt solution (HBSS; GIBCO); the adherent cells were cultivated for 24 h in D20STI, washed three times in HBSS to remove inhibitors and dead PMNs, and the assay started by adding 0.5 ml Dulbecco's plus 5% acidtreated (AT) dog serum. At this time, the cultures were devoid of granulocytes, as determined by microscopic observation. Cultures were monitored at 2 h and 24 h to insure that no fibrinolysis had occurred before starting the assay. 50-to 100-~l samples were Withdrawn and assayed for release of radioactivity in a Packard Gamma Counter (Packard Instrument Co., Inc., Downers Grove, Ill.). Cells were plated in duplicate or in serial dilutions for all the assays. Results are expressed as percent of the total radioactivity releasable/4 h/106 cells.
Plasminogen activator in conditioned medium (CM) was measured by collecting 50-to 100-~tl samples of cells kept in serum-free medium with 0.2% lactalbumin hydrolysate for 48 h, and measuring radioactivity released in the presence and absence of 2 ~g dog plasminogen on labeled fibrin plates. Plates contained 95,000 cpm trypsin-releasable 1251-fibrin; 1 U = 10% of total radioactivity releasable/4 h. For measurement in cell lysates cells were washed twice with HBSS, scraped from the dish in 0.5-1 ml of 0.1% Triton X-I00, and stored at -20°C, as described elsewhere (12, 13) . Protein was measured by the method of Lowry (14) using egg lysozyme as a standard. LYSOZYME ASSAY. Lysozyme secretion was measured in CM of cells kept in D10 for 48 h, from the initial rate of lysis of a suspension of Micrococcus lysodeikticus (spray-dried; Miles Laboratories, Inc., Miles Research Div.) using a recording spectrophotometer (15) .
Reagents
AT DOG SERUM. AT dog serum was prepared by adjusting the pH of dog serum (GIBCO) to 2 with 2 N HC1 in isotonic saline; after 30 min at room temperature, the pH was adjusted to 7.4 with 2 N NaOH in isotonic saline and filter sterilized (12) .
I~ASMI~OGES. Plasminogen was purified from dog serum by affinity chromatography on lysine-Sepharose according to the method of Deutsch and Mertz (16) .
Preparation of Sensitized Erythrocytes. Sheep erythrocytes coated with IgM and complement
[E(IgM)C] and the assay of ingestion were performed as described previously (17, 18) .
Trypomastigote-Killing Assay. 50 ~l of a suspension of purified trypomastigotes in Dulbecco's were added to macrophage monolayers on 13-mm round cover slips, at a 1:1 or 1:2 parasite per cell ratio, and incubated for 90-180 min at 37°C. At the end of the exposure period, cover slips were washed extensively to remove all extracellular parasites and either fixed for microscopic observation or replenished with complete medium (D10), and incubation continued at 37°C for the desired time. Percentage of macrophages infected, number of parasites per macrophage, and total cell number were counted in Giemsa-stained samples as previously described (9) .
Results

The Trypanocidal Activity of Macrophages
We have previously reported that resident mouse peritoneal macrophages or macrophages obtained from thioglycollate-stimulated animals fail to kill the trypomastigotes of T. cruzi, whereas epimastigotes are promptly destroyed within their phagolysosomes (9) . This prompted us to examine the role of acquired, cell-mediated immunity, elucidated in other systems in the destruction of intracellular parasites. For this purpose, we tested the ability of macrophages from T. cruzi-infected mice to deal with trypomastigotes in vitro. In addition, animals were also infected with BCG to examine the specificity of the acquired immunity. Finally, a comparison was made between the resident cells of infected animals and those evoked by a secondary intraperitoneal challenge with either HKT, H37Ra antigen, or a nonspecific irritant in the form of PP. These results are outlined in Table I. Resident macrophages from animals infected with T. cruzi showed no trypanocidal activity, when compared to macrophages from noninfected controls. However, when these animals, infected with T. cruzi for 2-6 wk, were challenged intraperitoneally with HKT, their macrophages were able to destroy approximately 70% of the ingested trypomastigotes. Similarly, macrophages from T.
cruzi-infected animals, challenged either with the unrelated antigen H37Ra or a nonspecific stimulant, were also able to kill equal numbers of organisms. The injection of HKT, H37Ra, or PP into noninfected animals was without influence on their microbicidal activity. Animals infected with BCG and challenged either with HKT or H37Ra antigens expressed a lower, but significant, trypanocidal activity compared with cells from animals infected with live trypanosomes.
Resident peritoneal macrophages from T. cruzi-or BCG-infected animals, harvested without a previous secondary challenge, displayed a trypanostatic, rather than trypanocidal activity, as can be seen in Figs. 1 A and 1 B. The intracellular parasites multiply at a slower rate in these cells. It is apparent intraperitoneally with HKT (5 x 10~), PP (1 ml of a 1% solution), and H37Ra (400 /~g in 1 ml PBS). Cells were harvested 2 days later, nonadherent cells removed by washing three times in HBSS, and macrophages cultivated for 24 h in D10 before infection. Cells were exposed to purified trypomastigotes at a 1:1 or 1:2 parasite/ cell multiplicity for 3 h; under these conditions about 30-35% of the original macrophage population is infected. Values represent numbers at (T 24 h/T 3 h) × 100.
that even T. cruzi infection and specific antigenic challenge yielded cell populations which could not completely inactivate the phagocytized inoculum. The surviving 30-40% of the ingested inoculum multiplied at a slower rate in these cells. However, after 72 h of cultivation, the remaining trypomastigotes in these cells, as well as the trypomastigotes in the immune resident cells, were multiplying at a normal rate and were able to parasitize uninfected cells in the monolayer.
We concluded from these experiments that the peritoneal macrophages from infected animals express significant trypanocidal activity only after a secondary challenge. In contrast, resident cells from immune animals, obtained without a secondary challenge express a trypanostatic, rather than trypanocidal activity. Employing these systems, other parameters of macrophage stimulation were next examined. 
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Macrophage Fibrinolytic Activity After Infection and Challenge with T. cruzi
Prior work had indicated that a plasminogen activator was secreted by macrophages activated by either thioglycollate medium (12) or endotoxin followed by particle ingestion (13) . It was therefore of interest to investigate the role of infection with intracellular parasites on the secretion of this product. cruzi on the fibrinolytic activity of cultivated mouse peritoneal macrophages.
No significant increase in fibrinolytic activity was found in macrophages harvested from mice infected 5 wk previously with T. cruzi (I). However, a marked increase in fibrinolytic activity was found when the infected animals had received an intraperitoneal challenge with HKT 3 days before harvesting. These cells (IB) showed a 7-to 15-fold increase over the unstimulated controls (C). The res;dent immune macrophages (I) did show a two-to threefold increase ._8 in fibrinolytic activity in some experiments, but after the challenge this activity was always enhanced an additional four-to fivefold. In contrast, the intraperitoneaI injection of HKT into noninfected controls (CB) yielded only an insignificant response although a similar amount of phagocytizable material was introduced into the cavity. Fig. 2 B illustrates the time-course of fibrinolysis, employing cells from the same sources, and shows the prompt and linear reaction of infected and boosted populations (IB). The appearance of these activated macrophages in the peritoneal cavity after a secondary challenge requires a previous infection (Table II) . The injection 3 wk before challenge of 5 × 106 HKT is not sufficient to generate macrophages with increased fibrinolytic activity. In contrast, infection with the same number of viable trypanosomes, followed 3 wk later by the intraperitoneal challenge with HKT yields macrophages which display enhanced fibrinolytic activity.
The Nature and Intracellular Localization of the Fibrinolytic Activity. The nature and distribution of the fibrinolytic activity of these activated macro- and boosted 2 wk later with 5 x 106 HKT. Peritoneal cells were harvested 2 days after the boost and macrophages cultivated for 2 days in medium containing FBS. The cultures were then washed and incubated for 2 days in serum-free medium. $ 50-to 100-/~1 samples were assayed in duplicate -2/~g dog plasminogen on fibrin plates containing 95,000 cpm trypsin-releasable l~I-fibrin. 1 U, 10% of total radioactivity releasable/4 h. Results in parentheses were obtained in the absence of added plasminogen.
phages was next examined. Table III confirmed that fibrinolysis was induced in macrophages from immune challenged mice and was strictly dependent upon the presence of added plasminogen. In addition, the plasminogen-dependent product was largely (70-80%) found in the extracellular medium in cells from both immune and immune-challenged animals. These findings strongly suggest the secretion of a plasminogen activator. Although not illustrated, lysozyme levels were only twofold higher in culture fluids from infected and challenged mice than in noninfected controls. 
Factors Modifying the Secretion of Plasminogen Activator by Macrophages. A detailed examination was next conducted on the in vivo events
which modified the expression of fibrinolysis by explanted macrophages.
THE DURATION OF INFECTION BEFORE CHALLENGE. Mice were given a sublethal infection and examined over the course of 13 wk. At intervals from 1 to 13 wk after infection the animals were challenged intraperitoneally with HKT, and the peritoneal cells harvested aider 2 days and explanted in vitro. Fig. 3 demonstrates the rapid elevation of fibrinolytic activity, reaching a maximum 3 wk after infection and persisting at somewhat lower levels for over 3 too. The fibrinolytic activity of the resident peritoneal macrophages from infected animals remained unaltered during this period. Spleen size increased 1.5-to 3-fold and, in general, paralleled the fibrinolytic activity.
THE INTRAPERITONEAL CHALLENGE-DOSE AND TIME OF HARVESTING. The effect of various amounts of HKT on the fibrinolytic activity of macrophages obtained from control and T. cruzi.infected animals is seen in Table IV . No significant alteration in fibrinolysis occurs in cells obtained from control mice. In contrast, macrophages from infected animals, obtained 2 days after challenge, expressed four-to sixfold higher activity when injected with 5 × 10 B HKT organisms. Significant stimulation is also seen with 1 × 10 ~ HKT but not with 5 × l0 b organisms.
A number of experiments were performed to evaluate the fibrinolytic activity of macrophages obtained 2-4 days after an intraperitoneal challenge with 5 × l0 s HKT. Cells obtained from noninfected mice exhibited low and constant levels of activity 2, 3, and 4 days postchallenge (3.3% cpm released/4 h/10 ~ cells). Infected animals, however, exhibited a sharp maximum 2 days ai~r challenge (18.9% cpm released/4 h/10 6 cells), decreasing progressively on days 3 and 4. This somewhat surprising reduction in fibrinolytic activity on the 3rd and 4th days was associated with poor macrophage viability and the presence of extremely vacuolated cells containing phagocytized debris. It should also be noted that considerable numbers of granulocytes are present in the 2-day exudates. These cells are, however, removed by in vitro cultivation (see Materials and Methods) and do not contribute to the macrophage response. To establish the specificity of the secondary challenge on the induction of plasminogen activator secretion, a comparison was made with cells obtained either from BCG-or T. cruzi-infected animals and noninfectod controls challenged intraperitoneally with HKT and PPD. In addition, a non-specific inflammatory agent in the form of PP was included for the intraperitoneal challenge of both infected and noninfected groups of animals. The results of such experiments are shown in Table V .
The intraperitoneal administration of PPD, HKT, or PP into noninfected controls resulted in cells with low levels of fibrinolytic activity, similar to those found in control, noninjected animals. T. cruzi-infected animals challenged with HKT or BCG-infected animals challenged with PPD yielded cells which exhibited a 10-to 15-fold increase in fibrinolytic activity. In contrast, intraperitoneal challenge with the unrelated antigen or nonspecific irritant yielded a less dramatic (threefold) but definite increase in activity. The strength of the response was therefore closely related to the specificity of the challenge antigen as well as the previous infected state of the animals.
Although the majority of the experiments were conducted with animals infected with the Y strain of T. cruzi, it was noted that intraperitoneal challenge with heat-killed organisms of either the Tulahu6n or Y strains gave similar results. This indicates a close antigenic relationship between these two strains of T. cruzi.
Infection and C-Mediated Phagocytosis
Prior studies had demonstrated that the ability of macrophages to ingest E(IgM)C was related to their degree of "activation" or stimulation (17, 18) . To examine this under conditions of chronic infection we employed both T. cruzi and BCG and compared the level of C-mediated ingestion in infected and challenged animals. Table VI outlines the results obtained. The expression of phagocytosis mediated by the C receptor is displayed nonspecifically by immune cells with or without challenge, as well as by cells from noninfected animals challenged intraperitoneally with the same inflammatory agents. Discussion We present data indicating that a sublethal infection with T. cruzi or BCG in mice, followed by an intraperitoneal challenge with the respective antigen, induces the appearance of macrophages which display microbicidal activity against trypomastigotes of T. cruzi. These activated macrophages also secrete large amounts of plasminogen activator, exhibit rapid spreading on glass or plastic surfaces, and ingest C-coated erythrocytes.
The trypanocidal activity displayed by these activated macrophages is not totally efficient, and a small percentage of the phagocytized trypomastigote inoculum survives and multiplies after 72 h. If the cultures are followed for longer periods of time, the infection spreads to the previously resistant cells. This could be due either to a loss of the microbicidal and microbistatic properties of the macrophages upon cultivation, or, less likely, to the survival of a resistant population of parasites.
A previous report by Hoff (7) has indicated that BCG-and T. cruzi-immune macrophages were microbicidal in vitro for culture forms of T. cruzi. In this
TABLZ VI
Complement-Mediated Ingestion by Peritoneal Macrophages
Infection Challenge E(IgM)C ingestion, %* 
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system, the T. cruzi-immune cells were resident peritoneal cells obtained without a secondary challenge. In our experience, such cells do not display microbicidal activity against trypomastigotes, but only a microbistatic effect which delays the growth of the parasites. The difference in the two reports may be explained by two factors. In HoiTs system, the challenging inoculum consisted of total culture forms which contained only 5-15% trypomastigotes, and at least 85% epimastigotes. We have previously shown that epimastigotes are destroyed by normal macrophages. In addition, the cells were not followed longer than 72 h. Therefore, it is likely that the apparent microbicidal activity was only reflecting intracellular killing of epimastigotes and inhibition of growth of the few trypomastigotes in the ingested inoculum. Infections caused by facultative intracellular bacteria have been shown to provoke an immune response associated with delayed-type hypersensitivity, not transmissible by serum, and resulting in the formation of immunologically committed lymphoid cells and activation of macrophages (19) . Thymus-derived lymphocytes have been implicated as the cell population carrying the specificity of the response (20, 21) and macrophages can be activated by them to become effectors which can kill a variety of immunologically unrelated organisms (22) . This may help us to explain the observation that macrophages obtained from BCG-infected animals have significant microbicidal activity against T. cruzi trypomastigotes and is in general consistent with the data of Mackaness for bacterial (23) , and Hoff (7) and Mauel and Behin (24) for protozoan systems. In other protozoan systems, authors have stressed the specificity for the microbicidal or microbistatic properties of macrophages (25, 26) .
In keeping with the prior observations of others, viable organisms were necessary to provide a persisting antigenic load, and immunization with HKT was ineffective in modifying cell-mediated immunity. In contrast to these other bactericidal systems, a secondary intraperitoneal challenge was required with either T. cruzi or BCG infections to yield trypanocidal macrophages. The conversion of a trypanostatic to a trypanocidal effect after the secondary challenge of infected animals may depend on at least two factors. First, the intraperitoneal influx of a larger population of sensitized lymphocytes which can in turn alter macrophage function (27) . Second, the influence of products generated during the local inflammatory process, which might influence both lymphocytes and macrophages. The presence of lymphokines, persisting antigen, and inflammatory products may explain the apparent lack of antigenic specificity elicited by the secondary challenge on the trypanocidal activity. Macrophages activated either through the generation of an inflammatory environment or through microbial infection display other properties, such as rapid spreading on glass or plastic surfaces (28) , increase in lysosomal hydrolases (11), metabolic perturbations, tumoricidal effects (29, 30) , and the ingestion of C-coated erythrocytes (18) . Inflammatory macrophages induced with thioglycollate broth have been shown to secrete large amounts of neutral proteases, such as plasminogen activator (12) , elastase (31) , and collagenase (32) . Cells from T. cruzi-and BCGoinfected animals, harvested after a secondary challenge, also secrete enhanced amounts of plasminogen activator. Both the increased secretory activity and trypanocidal activity have a parallel time-course. Increased secretion of plasminogen activator was found as early as 1 wk after infection and challenge, and microbicidal activity was present from the 2nd wk on. Peak activity in both cases was found at 3 wk, when spleen size was also very enlarged. However, these two properties are probably not related since thioglycollate-activated macrophages secrete large amounts of plasminogen activator but do not display trypanocidal activity.
The induction of plasminogen activator secretion under the conditions employed in this study showed a definite immunological specificity in keeping with the trypanocidal results. These findings could not be explained on the basis of particle ingestion since a soluble antigen in the form of PPD elicits the response in BCG-infected animals. One explanation for these data is a role for products of specifically sensitized lymphoid elements. This possibility has been examined and is presented in the accompanying publication.
The cells obtained after a specific, secondary antigenic challenge also exhibited a number of other properties. Rapid, symmetrical spreading leads to flattened cells with intensely ruffled plasma membrane and numerous pinocytic vesicles. This appearance was maintained in culture for many days, even in the absence of serum in the medium. If cells were harvested 2 days after challenge, their appearance was as that described above. However, harvesting at 3 and 4 days led to a population which was heavily vacuolated and which died rapidly upon in vitro cultivation. The nature of this cytotoxic effect is unknown. Another attribute is their ability to ingest E(IgM)C via the C receptor. This property, described initially with thioglycollate-induced populations does not depend upon a specific antigenic challenge and is expressed by noninfected animals challenged with all the agents employed. It would seem that this may be the result of mediators generated during an inflammatory event and is in keeping with the prior observations on macrophage spreading in which C components and coagulation factors play significant roles (33) .
Summary
Infection of mice with Trypanosoma cruzi and subsequent intraperitoneal challenge with heat-killed trypanosomes elicits peritoneal macrophages which display in vitro microbicidal activity against trypomastigotes of T. cruzi. These cells also display other activated properties including rapid spreading, intense membrane activity, secretion of high levels of plasminogen activator, and ingestion mediated by the C3 receptor.
An intravenous infection with BCG, followed by an intraperitoneal challenge with mycobacterial antigens brings about macrophages with similar properties. These criteria of macrophage activation were compared in normal and BCG-or T. cruzi-immune mice, with or without an intraperitoneal challenge with specific or unrelated antigens. Trypanocidal activity is displayed by both BCGand T. cruzi-immune macrophages after intraperitoneal challenge with either antigen. Resident-immune macrophages from both T. cruzi-and BCG-infected mice show a trypanostatic, rather than trypanocidal activity. Macrophages from noninfected mice, challenged with the same antigens, show neither trypanostatic nor trypanocidal activity.
Increased secretion of plasminogen activator shows a definite immunological specificity. Challenge with the specific antigen induces the appearance of macrophages secreting high levels of plasminogen activator, while unrelated antigens induce much smaller levels. Noninfected mice challenged with the same antigens do not display any enhancement in secretion. In contrast, increased spreading and phagocytosis mediated by the complement receptor are also displayed by cells from noninfected mice challenged with any of the agents tested.
